03 Nov '22
Talis Biomedical Reports Third Quarter 2022 Financial Results
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported
10 May '22
Talis Biomedical Announces First Quarter 2022 Financial Results
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment